Form 8-K - Current report:
SEC Accession No. 0001299933-10-003084
Filing Date
2010-08-13
Accepted
2010-08-13 17:29:52
Documents
2
Period of Report
2010-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_38733.htm 8-K 11429
2 EX-10.7 exhibit1.htm EX-10.7 199471
  Complete submission text file 0001299933-10-003084.txt   212400
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 101016405
SIC: 2834 Pharmaceutical Preparations